Edition:
United Kingdom

Bliss GVS Pharma Ltd (BLIS.NS)

BLIS.NS on National Stock Exchange of India

202.85INR
19 Jan 2018
Change (% chg)

Rs1.80 (+0.90%)
Prev Close
Rs201.05
Open
Rs199.10
Day's High
Rs204.75
Day's Low
Rs198.70
Volume
956,295
Avg. Vol
318,354
52-wk High
Rs220.25
52-wk Low
Rs129.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 2,265.50 4.930
Jun 2,255.67 3.580
FY 2017 Mar '17 2,446.35 3.564
Dec 2,321.98 1.400
Sep 1,690.07 2.460
Jun 1,410.97 2.670
FY 2016 Mar '16 1,358.32 1.714
Dec 1,323.83 2.154
Sep 1,760.73 2.234
Jun 948.82 1.895
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 15.94 31.10 32.90
P/E High - Last 5 Yrs. 22.16 40.98 46.03
P/E Low - Last 5 Yrs. 4.74 23.80 24.39
Beta 0.61 0.90 0.89
Price to Sales (TTM) 1.83 3.98 5.45
Price to Book (MRQ) -- 4.82 5.38
Price to Tangible Book (MRQ) -- 5.57 6.89
Price to Cash Flow (TTM) 11.00 23.02 23.43
% Owned Institutions -- 1.23 2.16

Dividends

  Company industry sector
Dividend Yield 0.38 1.56 1.50
Dividend Yield - 5 Year Avg 0.60 1.57 1.51
Dividend 5 Year Growth Rate -4.36 4.35 5.23
Payout Ratio(TTM) 0.00 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 59.87 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago 49.24 4.69 5.44
Sales - 5 Yr. Growth Rate 24.53 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 34.08 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago 12.49 -- --
EPS - 5 Yr. Growth Rate 10.26 9.86 10.77
Capital Spending - 5 Yr. Growth Rate 42.77 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) -- 2.88 2.97
LT Debt to Equity (MRQ) -- 9.81 12.10
Total Debt to Equity (MRQ) -- 13.80 16.38
Interest Coverage (TTM) 8.35 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 54.27 55.13 54.76
Gross Margin - 5 Yr. Avg. 52.35 52.41 52.45
EBITD Margin (TTM) 24.67 -- --
EBITD - 5 Yr. Avg 25.91 18.54 15.33
Operating Margin (TTM) 22.23 14.40 7.60
Operating Margin - 5 Yr. Avg. 23.32 14.46 10.79
Pre-Tax Margin (TTM) 22.00 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. 24.19 14.77 11.19
Net Profit Margin (TTM) 14.21 11.09 4.70
Net Profit Margin - 5 Yr. Avg. 15.17 11.11 7.50
Effective Tax Rate (TTM) 35.41 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. 37.28 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 19,891,340 948,195,516 855,725,045
Net Income/Employee (TTM) 2,826,917 111,561,295 100,665,187
Receivable Turnover (TTM) -- 5.61 5.76
Inventory Turnover (TTM) -- 2.57 3.34
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.41 10.97
Return on Assets - 5 Yr. Avg. 11.73 12.98 12.39
Return on Investment (TTM) -- 14.84 14.40
Return on Investment - 5 Yr. Avg. 18.93 16.97 16.20
Return on Equity (TTM) -- 16.32 16.09
Return on Equity - 5 Yr. Avg. 19.90 18.05 17.53
  1 Year 3 Year 5 Year
Sales % 46.23 32.39 24.53
EPS (TTM) % 3.79 27.82 10.26
Dividend % 20.00 6.27 -4.36
Note: Units in Millions of US Dollars

Performance for Bliss GVS Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -4.15 -4.53 99 25
13 Week 4.10 2.62 99 36
26 Week -5.92 -12.16 99 31
52 Week 11.05 -1.89 99 12
YTD 0.96 -15.50 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.64%
# of Holders: 7
Total Shares Held: 5,812,563
3 Mo. Net Change: -261,531
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 4
# Reduced Positions: 2
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.